Seraph® Clinical Trial
ExThera Medical has completed a multi-center, non-randomized European trial for the Seraph® Microbind® Affinity Blood Filter (Seraph). The study enrolled 15 patients at four centers in Germany.
The trial is designed to determine the safety and performance of the Seraph for reducing bacteremia in patients on hemodialysis, including MRSA, S. aureus, K. pneumoniae (CRE), K. pneumoniae, E. coli (CRE), E. coli, S. pneumoniae, E. faecalis, E. faecalis (VRE), E. faecium, A. baumannii, S. epidermidis, Methicillin resistant S. epidermidis, S. pyogenes, and Serratia marcescens.
Additional details about the study can be obtained by visiting https://clinicaltrials.gov/show/NCT02914132. CinicalTrials.gov Identifier: NCT02914132